4-HYDROXYANDROSTENEDIONE ALONE AND IN COMBINATION WITH ZOLADEX IN PREMENOPAUSAL BREAST-CANCER

被引:0
作者
STEIN, RC
DOWSETT, M
HEDLEY, A
COOMBES, RC
机构
[1] ST GEORGES HOSP,CLIN ONCOL UNIT,LONDON SW17 0RE,ENGLAND
[2] CHELSEA HOSP WOMEN,LONDON SW3 6LT,ENGLAND
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:824 / 824
页数:1
相关论文
共 50 条
[31]   INVIVO AND INSITU TUMOR AROMATASE-ACTIVITY IN POST-MENOPAUSAL WOMEN WITH BREAST-CANCER - EFFECT OF 4-HYDROXYANDROSTENEDIONE [J].
REED, MJ ;
GHILCHIK, MW ;
LAI, LC ;
OWEN, AM ;
SINGH, A ;
COLDHAM, NG ;
SHAIKH, NA ;
JAMES, VHT .
BRITISH JOURNAL OF SURGERY, 1988, 75 (12) :1230-1231
[32]   AROMATIZATION INHIBITION ALONE OR IN COMBINATION WITH GNRH AGONISTS FOR THE TREATMENT OF PREMENOPAUSAL BREAST-CANCER PATIENTS [J].
DOWSETT, M ;
STEIN, RC ;
COOMBES, RC .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 43 (1-3) :155-159
[33]   ZOLADEX IN ADVANCED BREAST-CANCER [J].
ROBERTSON, JFR ;
NICHOLSON, RI ;
WALKER, KJ ;
BLAMEY, RW .
HORMONE RESEARCH, 1989, 32 :206-208
[34]   CONCENTRATIONS OF ESTRONE AND 4-HYDROXYANDROSTENEDIONE IN MALIGNANT AND NORMAL BREAST TISSUES [J].
REED, MJ ;
AHERNE, GW ;
GHILCHIK, MW ;
PATEL, S ;
CHAKRABORTY, J .
INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (04) :562-565
[35]   HORMONAL FOLLOW-UP TREATMENTS WITH ZOLADEX FOR PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER [J].
VONMINCKWITZ, G ;
KAUFMANN, M ;
MOHRLE, D ;
SCHMID, H ;
BASTERT, G .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1991, 250 (1-4) :258-260
[36]   AROMATASE INHIBITION BY 4-HYDROXYANDROSTENEDIONE IN ADVANCED PROSTATIC-CANCER [J].
DAVIES, JH ;
DOWSETT, M ;
COOMBES, RC ;
SHEARER, RJ .
BRITISH JOURNAL OF CANCER, 1989, 60 (03) :492-492
[37]   Isotopic dilution GC-MS measurement of 4-hydroxyandrostenedione in postmenopausal breast cancer [J].
Danza, G ;
Dini, S ;
Bartolucci, G ;
Lentini, G ;
Becorpi, A ;
Massi, GB ;
Guarna, A ;
Serio, M .
ENDOCRINE-RELATED CANCER, 1996, 3 (02) :137-143
[38]   EFFECT OF 2 4-HYDROXYANDROSTENEDIONE DOSES ON SERUM INSULIN-LIKE GROWTH-FACTOR-I LEVELS IN ADVANCED BREAST-CANCER [J].
FERRARI, L ;
ZILEMBO, N ;
BAJETTA, E ;
BUZZONI, R ;
NOBERASCO, C ;
MARTINETTI, A ;
CELIO, L ;
GALANTE, E ;
OREFICE, S ;
CERROTTA, AM .
BREAST CANCER RESEARCH AND TREATMENT, 1994, 30 (02) :127-132
[39]   THE USE OF AN LH-RH AGONIST (ICI 118630, ZOLADEX) IN ADVANCED PREMENOPAUSAL BREAST-CANCER [J].
WILLIAMS, MR ;
WALKER, KJ ;
TURKES, A ;
BLAMEY, RW ;
NICHOLSON, RI .
BRITISH JOURNAL OF CANCER, 1986, 53 (05) :629-636
[40]   EFFECT OF TREATMENT WITH 4-HYDROXYANDROSTENEDIONE ON THE PERIPHERAL CONVERSION OF ANDROSTENEDIONE TO ESTRONE AND INVITRO TUMOR AROMATASE-ACTIVITY IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER [J].
REED, MJ ;
LAI, LC ;
OWEN, AM ;
SINGH, A ;
COLDHAM, NG ;
PUROHIT, A ;
GHILCHIK, MW ;
SHAIKH, NA ;
JAMES, VHT .
CANCER RESEARCH, 1990, 50 (01) :193-196